129 related articles for article (PubMed ID: 16167062)
1. MDM2 promoter variation and age of diagnosis of acute lymphoblastic leukemia.
Swinney RM; Hsu SC; Hirschman BA; Chen TT; Tomlinson GE
Leukemia; 2005 Nov; 19(11):1996-8. PubMed ID: 16167062
[No Abstract] [Full Text] [Related]
2. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
[TBL] [Abstract][Full Text] [Related]
3. The novel susceptibility variants for childhood acute lymphoblastic leukemia.
Perez-Andreu V; Xu H; Yang JJ
J Natl Cancer Inst; 2013 Oct; 105(19):1512-3. PubMed ID: 24013180
[No Abstract] [Full Text] [Related]
4. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.
Zhou M; Yeager AM; Smith SD; Findley HW
Blood; 1995 Mar; 85(6):1608-14. PubMed ID: 7888679
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of NF-kappaB/P65 by MDM2 in acute lymphoblastic leukemia in childhood].
Hu Q; Zhou MX; Liu SY; Zhang LQ; Liu AQ; Guo YJ; Song Y
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):921-4. PubMed ID: 14723816
[TBL] [Abstract][Full Text] [Related]
6. High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.
Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Brodsky I; Haines DS
Blood; 1996 Feb; 87(3):1155-61. PubMed ID: 8562942
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MDM2 in acute childhood lymphoblastic leukemia.
Gustafsson B; Stål O; Gustafsson B
Pediatr Hematol Oncol; 1998; 15(6):519-26. PubMed ID: 9842645
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California.
Aldrich MC; Zhang L; Wiemels JL; Ma X; Loh ML; Metayer C; Selvin S; Feusner J; Smith MT; Buffler PA
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):578-81. PubMed ID: 16537719
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia.
Zhou M; Gu L; Abshire TC; Homans A; Billett AL; Yeager AM; Findley HW
Leukemia; 2000 Jan; 14(1):61-7. PubMed ID: 10637478
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in MDM2 and P53 genes confer risk for adult acute lymphoblastic leukemia in a Chinese population.
Chen J; Zhu B; Chen J; Li Y
DNA Cell Biol; 2013 Jul; 32(7):414-9. PubMed ID: 23745682
[TBL] [Abstract][Full Text] [Related]
11. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.
Gu L; Findley HW; Zhou M
Blood; 2002 May; 99(9):3367-75. PubMed ID: 11964305
[TBL] [Abstract][Full Text] [Related]
12. No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.
Millikan RC; Heard K; Winkel S; Hill EJ; Heard K; Massa B; Mayes L; Williams P; Holston R; Conway K; Edmiston S; de Cotret AR
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):175-7. PubMed ID: 16434608
[No Abstract] [Full Text] [Related]
13. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia].
Bartkowiak J; Wójcik I; Stankiewicz W
Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808
[TBL] [Abstract][Full Text] [Related]
14. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
15. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence.
Yang W; Treviño LR; Yang JJ; Scheet P; Pui CH; Evans WE; Relling MV
Leukemia; 2010 Apr; 24(4):894-6. PubMed ID: 20054350
[No Abstract] [Full Text] [Related]
16. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and p53 in childhood acute lymphoblastic leukemia: higher expression in childhood leukemias with poor prognosis compared to long-term survivors.
Gustafsson B; Axelsson B; Gustafsson B; Christensson B; Winiarski J
Pediatr Hematol Oncol; 2001 Dec; 18(8):497-508. PubMed ID: 11764099
[TBL] [Abstract][Full Text] [Related]
18. [Study on MDM2 and p53 gene proteins expression on acute leukemic cells and its correlation with chemotherapeutic efficacy].
Lin M; Liu Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):350-2. PubMed ID: 11189516
[TBL] [Abstract][Full Text] [Related]
19. The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.
Xu L; Wu H; Wu X; Li Y; He D
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e124-e128. PubMed ID: 28544358
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia.
Mittelman SD; Kim J; Raca G; Li G; Oberley MJ; Orgel E
Blood; 2021 Jul; 138(2):199-202. PubMed ID: 33876219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
